Halozyme Therapeutics
HALO
#2184
Rank
NZ$12.57 B
Marketcap
$98.85
Share price
-0.30%
Change (1 day)
76.23%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): NZ$0.77 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$0.94 Billion. In 2023 the company made an earning of NZ$0.61 Billion, an increase over its 2022 earnings that were of NZ$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.77 B25.55%
2023 NZ$0.61 B39.94%
2022 NZ$0.44 B0.16%
2021 NZ$0.44 B92.2%
2020 NZ$0.22 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.15 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.19 Billion216.03%
2015 -NZ$57.07 Million-52.86%
2014 -NZ$0.13 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$94.82 Million169.94%
2011 -NZ$35.13 Million-63.44%
2010 -NZ$96.07 Million-7.19%
2009 -NZ$0.11 Billion15.91%
2008 -NZ$89.3 Million83.89%
2007 -NZ$48.56 Million78.1%
2006 -NZ$27.27 Million16%
2005 -NZ$23.51 Million45.24%
2004 -NZ$16.19 Million682.42%
2003 -NZ$2.07 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$44.32 M-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.97 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.29 B-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.29 B 1,346.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.11 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$32.56 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA